Effect of cigarette smoking on coumarin metabolism in humans

Russell E. Poland; Robert N. Pechnick; Christine C. Cloak; Yu-Jui Yvonne Wan; Inocencia Nuccio; Keh Ming Lin

doi:10.1080/713688151

Effect of cigarette smoking on coumarin metabolism in humans

Russell E. Poland, Robert N. Pechnick, Christine C. Cloak, Yu-Jui Yvonne Wan, Inocencia Nuccio, Keh Ming Lin

Research output: Contribution to journal › Article › peer-review

14 Scopus citations

Abstract

Extant data, mostly from studies in vitro, suggest that coumarin and nicotine are both metabolized by CYP2A6, a cytochrome P450 isozyme. In order to investigate this issue further, the activity of this enzyme in vivo was measured in 37 non-smokers and 37 smokers using coumarin (2.0 mg, PO) as the metabolic probe. The percentage of coumarin metabolized to 7-hydroxycoumarin in 8 h was measured in urine by high-pressure liquid chromatography. There was more than 10-fold variability in coumarin metabolism in both groups. Coumarin metabolism was significantly reduced in smokers (46.6±4.4%) as compared to non-smokers (66.4±3.5%; p≤.001). The results support previous in vitro findings that both coumarin and nicotine are metabolized, at least in part, by a common pathway, which most likely is CYP2A6.

Original language	English (US)
Pages (from-to)	351-354
Number of pages	4
Journal	Nicotine and Tobacco Research
Volume	2
Issue number	4
DOIs	https://doi.org/10.1080/713688151
State	Published - Jan 1 2000
Externally published	Yes

ASJC Scopus subject areas

Public Health, Environmental and Occupational Health

Access to Document

10.1080/713688151

Fingerprint Dive into the research topics of 'Effect of cigarette smoking on coumarin metabolism in humans'. Together they form a unique fingerprint.

Cite this

@article{5cd7eca7f3e64033b2db5cc617df8c5f,

title = "Effect of cigarette smoking on coumarin metabolism in humans",

abstract = "Extant data, mostly from studies in vitro, suggest that coumarin and nicotine are both metabolized by CYP2A6, a cytochrome P450 isozyme. In order to investigate this issue further, the activity of this enzyme in vivo was measured in 37 non-smokers and 37 smokers using coumarin (2.0 mg, PO) as the metabolic probe. The percentage of coumarin metabolized to 7-hydroxycoumarin in 8 h was measured in urine by high-pressure liquid chromatography. There was more than 10-fold variability in coumarin metabolism in both groups. Coumarin metabolism was significantly reduced in smokers (46.6±4.4%) as compared to non-smokers (66.4±3.5%; p≤.001). The results support previous in vitro findings that both coumarin and nicotine are metabolized, at least in part, by a common pathway, which most likely is CYP2A6.",

author = "Poland, {Russell E.} and Pechnick, {Robert N.} and Cloak, {Christine C.} and Wan, {Yu-Jui Yvonne} and Inocencia Nuccio and Lin, {Keh Ming}",

year = "2000",

month = jan,

day = "1",

doi = "10.1080/713688151",

language = "English (US)",

volume = "2",

pages = "351--354",

journal = "Nicotine and Tobacco Research",

issn = "1462-2203",

publisher = "Oxford University Press",

number = "4",

}

TY - JOUR

T1 - Effect of cigarette smoking on coumarin metabolism in humans

AU - Poland, Russell E.

AU - Pechnick, Robert N.

AU - Cloak, Christine C.

AU - Wan, Yu-Jui Yvonne

AU - Nuccio, Inocencia

AU - Lin, Keh Ming

PY - 2000/1/1

Y1 - 2000/1/1

N2 - Extant data, mostly from studies in vitro, suggest that coumarin and nicotine are both metabolized by CYP2A6, a cytochrome P450 isozyme. In order to investigate this issue further, the activity of this enzyme in vivo was measured in 37 non-smokers and 37 smokers using coumarin (2.0 mg, PO) as the metabolic probe. The percentage of coumarin metabolized to 7-hydroxycoumarin in 8 h was measured in urine by high-pressure liquid chromatography. There was more than 10-fold variability in coumarin metabolism in both groups. Coumarin metabolism was significantly reduced in smokers (46.6±4.4%) as compared to non-smokers (66.4±3.5%; p≤.001). The results support previous in vitro findings that both coumarin and nicotine are metabolized, at least in part, by a common pathway, which most likely is CYP2A6.

AB - Extant data, mostly from studies in vitro, suggest that coumarin and nicotine are both metabolized by CYP2A6, a cytochrome P450 isozyme. In order to investigate this issue further, the activity of this enzyme in vivo was measured in 37 non-smokers and 37 smokers using coumarin (2.0 mg, PO) as the metabolic probe. The percentage of coumarin metabolized to 7-hydroxycoumarin in 8 h was measured in urine by high-pressure liquid chromatography. There was more than 10-fold variability in coumarin metabolism in both groups. Coumarin metabolism was significantly reduced in smokers (46.6±4.4%) as compared to non-smokers (66.4±3.5%; p≤.001). The results support previous in vitro findings that both coumarin and nicotine are metabolized, at least in part, by a common pathway, which most likely is CYP2A6.

UR - http://www.scopus.com/inward/record.url?scp=85047675330&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85047675330&partnerID=8YFLogxK

U2 - 10.1080/713688151

DO - 10.1080/713688151

M3 - Article

C2 - 11197315

AN - SCOPUS:85047675330

VL - 2

SP - 351

EP - 354

JO - Nicotine and Tobacco Research

JF - Nicotine and Tobacco Research

SN - 1462-2203

IS - 4

ER -